Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Biogen Reports ELOCTATE™ Shows Positive Implications for Quality of Life
Biogen Reports ELOCTATE™ Shows Positive Implications for Quality of Life
Industry
Genentech Patient Foundation/Medvantx Announce Ancillary Safety Issue
Alnylam Reports Progress on Investigational Subcutaneous Hemophilia…
Industry
Pfizer to Build Gene Therapy Facility in North Carolina
Spark Reports Positive Data from Hemophilia B Gene Therapy Program
Industry
uniQure Announces Updated Hemophilia B Gene Therapy Data
Sangamo Reports Hemophilia A Gene Therapy Progress at ASH
Industry
Octapharma Announces Two New Clinical Trials
Octapharma Announces Two New Clinical Trials
Industry
Sangamo’s SB-FIX Receives FDA's Orphan Drug Status
Sangamo’s SB-FIX Receives FDA's Orphan Drug Status
Industry
Bayer Announces 2016 BHAP Recipients
Bayer Announces 2016 BHAP Recipients
Industry
Novo Presents Initial Results of B-HERO-S Study
Novo Presents Initial Results of B-HERO-S Study
Industry
BioMarin Reports Continued Progress in Clinical Trial for Hemophilia A Gene Therapy
Spark Announces New Data on Its FIX Gene Therapy
Industry
UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site
UniQure’s Gene Therapy Performing well in Hemophilia B Trial
Industry
Shire/Baxalta Complete $32 Billion Merger
Shire/Baxalta Complete $32 Billion Merger
Industry
ACE910 Shows Positive Efficacy and Safety Data in Phase I Trial
ACE910 Shows Positive Efficacy and Safety Data in Phase I Trial
Industry
Sangamo Reports Early Progress in Pre-Clinical Hemophilia A Gene Therapy Studies
Sangamo Reports Early Progress in Pre-Clinical Hemophilia A Gene…
Industry
Preliminary Data Show Progress for BioMarin’s Factor VIII Gene Therapy
Preliminary Data Show Progress for BioMarin’s Factor VIII Gene Therapy
Industry
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves Generic Version of Tranexamic Acid